Clinical Trial Update: A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy [Phase 4]

View source ↗

Summary

A Phase 4 study of Recormon (epoetin beta) in anemic patients with non-myeloid malignancy has been terminated. The entry communicates the trial status rather th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Recormon (epoetin beta)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 4 | Status: TERMINATED